Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-25

FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NASCOBAL (cyanocobalamin) submitted by ENDO USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASCOBAL (cyanocobalamin)

Snippet

SUPPL AP for NASCOBAL (CYANOCOBALAMIN)